Which Berry Is Most Likely To Be Contaminated? A Food Safety Expert Breaks It Down Amid New FDA Rules
Because of this, the Food and Drug Administration (FDA) announced on January 17 that the agency is implementing a new strategy to lower the risk of certain viruses ending up in your berries. They're ...
Quality Assurance16h
FDA Releases Prevention Strategy for Control of Enteric Viruses in Berries
Over many years, outbreaks of enteric virus infections, including Hepatitis A Virus (HAV) and human norovirus (NoV), have ...
gna18h
Haven of Love Children’s Foundation holds funfair for children
Jan. 23, GNA -The Haven of Love Children’s Foundation, a Christian Non-Governmental Organization (NGO), has organized a funfair for children and ...
News Medical21h
AGA releases updated guidelines on hepatitis B reactivation in patients on immunosuppressive drugs
The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...
Food Safety News1d
Researchers work to develop faster, more accurate virus detection for produce
Researchers in Spain are working to develop faster, more accurate methods for detecting viruses like human norovirus and hepatitis A in fresh produce. The ...
Hosted on MSN1d
FDA breakthrough status for Bluejay’s CHD therapy brelovitug
Breakthrough therapy designation recognises the potential of brelovitug to transform the lives of people living with CHD. We ...
FDA Changes Food Safety Protocol for Fresh and Frozen Berries
The FDA just announced changes to help make berries sold in the U.S. safer to eat, lowering the odds you’ll get norovirus or ...
Agri-Pulse2d
FDA releases new strategy to prevent viruses in berries
The Food and Drug Administration released a new national strategy to prevent foodborne illnesses in fresh and frozen berries that the frozen food industry says align with voluntary guidance.
Monthly Prescribing Reference2d
Brelovitug Granted Breakthrough Designation for Chronic Hepatitis Delta
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).